Evidence map›Paper›PMID 38192437›Full record

ArticleBioMed research international2023

Antibacterial and Immunoregulatory Effects of Metformin against

Hassan Valadbeigi, Saeed Khoshnood, Babak Negahdari, Mohd Azmuddin Abdullah, Mohammad Hossein Haddadi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Antimicrobial and Synergistic Activity of Metformin AgainstThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  3. Observational
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hassan Valadbeigi *Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID https://orcid.org/0000-0003-0473-8742
Saeed Khoshnood *Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID https://orcid.org/0000-0002-5143-3178
Babak NegahdariDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-8742-9138
Mohd Azmuddin AbdullahSciCo Science and Technology Center, Mody Rd 62. Yau Tsim Mong District, Kowloon, Hong Kong SAR, China.
Mohammad Hossein HaddadiClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID https://orcid.org/0000-0002-3387-9379
Medical University of Ilam · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Forty-five male Sprague-Dawley rats were divided into seven groups and infected with Results: Metformin showed weak antibacterial activity against clinically isolated Conclusions: The combination of metformin with potential antibiotics such as AMX had a positive effect on the relief of

Indexed as

Helicobacter InfectionsHelicobacter pyloriAmoxicillinAnimalsAnti-Bacterial AgentsInflammationInterleukin-8MaleRatsRats, Sprague-DawleyTransforming Growth Factor betaAmoxicillinAnti-Bacterial AgentsInterleukin-8Transforming Growth Factor beta

Identifiers

PMID38192437
PMCPMC10774005
OpenAlexW4388851557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.